Peripheral NK cells identified as the predictor of response in extensive-stage small cell lung cancer patients treated with first-line immunotherapy plus chemotherapy

CONCLUSION: In patients with ES-SCLC, the percentage and changes in peripheral NK cells can predict the response to combined immunotherapy and chemotherapy.PMID:38662170 | DOI:10.1007/s12094-024-03479-4

Source: Clinical Lung Cancer - April 25, 2024 Category: Cancer & Oncology Authors: Yanan Cui Yanping Chen Peiyan Zhao Shuang Li Ying Cheng Xiubao Ren Source Type: research